116089 ⎘
Transferases transferring phosphorus-containing groups (2.7); Dual-specificity kinases (2.7.12) Mitogen-activated protein kinase kinase (2.7.12.2), i.e. MAPKK or MEK1 or MEK2
COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS USING A CD14 INHIBITOR
#2MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors
#3ACTIVATING MITOTIC CHECKPOINT CONTROL MECHANISMS
#4RECOMBINANT PROTEINS FOR QUANTIFICATION OF PROTEIN LEVELS
#5ENHANCING DROUGHT, SALINITY AND COLD TOLERANCE IN PLANTS AND TREES
#6MEK1 mutation conferring resistance to RAF and MEK inhibitors
#7ACTIVATING MITOTIC CHECKPOINT CONTROL MECHANISMS
#8MEK1 mutation conferring resistance to RAF and MEK inhibitors
#9Synergistic cancer treatment
#10METHODS AND BIOMARKERS FOR DETECTION AND TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS
#11Virus Vectors Expressing Multiple Epitopes of Tumor Associated Antigens For Inducing Antitumor Immunity
#12Methods and compositions for reducing blood glucose levels
#13Mps1 and KNL1 phosphorylation system
#14TOPK peptides and vaccines including the same
#15MEK1 mutation conferring resistance to RAF and MEK inhibitors
#16Method for increasing pathogen resistance in plants
#17Method for reducing blood glucose
#18Methods and compositions for reducing blood glucose
#19MEK ligands and polynucleotides encoding MEK ligands
#20GENETICALLY ENCODED PHOTO CONTROL
#21HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS
#22Transfection results of non-viral gene delivery systems by influencing of the innate immune system
#23MEK ligands and polynucleotides encoding MEK ligands